Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > December 2013 - Volume 20 - Issue 12 > Estimation of abdominal fat mass: validity of abdominal bioe...
Menopause:
doi: 10.1097/GME.0b013e31828f5cd8
Brief Report

Estimation of abdominal fat mass: validity of abdominal bioelectrical impedance analysis and a new model based on anthropometry compared with dual-energy x-ray absorptiometry

Manios, Yannis PhD1; Kanellakis, Spyridon MSc1; Moschonis, George MSc1; Pipidis, Ilias BSc2; Skoufas, Efstathios BSc2; Zafiropulos, Vassilis PhD2

Collapse Box

Abstract

Objective

Since abdominal adiposity has been associated with increased risk for chronic diseases, valid and low cost methods to estimate it are needed for clinical and research purposes. The aim of the current study was to develop and validate, using dual-energy x-ray absorptiometry (DXA) as reference method, a model that estimates abdominal fat mass percentage (AFM%) in white postmenopausal women based on simple and easy-to-apply anthropometric measurements. An additional aim was to validate an abdominal bioelectrical impedance analyzer (ViScan) for estimating waist circumference (WC) and AFM% in this group.

Methods

Ninety-one postmenopausal women (mean age, 61.5 y) with body mass index ranging from 20.9 to 42 kg/m2 were randomly divided into one training set (n = 60) and one testing set (n = 31) to develop and validate a model based on anthropometric measurements estimating abdominal fat mass. Furthermore, in all 91 participants, ViScan estimations of WC and AFM% were validated against tape measurement and DXA results.

Results

The model developed was AFM% = 4.496 + (0.318 × WC) + 0.342 × suprailiac skinfold (r = 0.834, P < 0.0001). The model had no significant bias (0.25%) and ±7.5% limits of agreement. ViScan significantly overestimated WC by 7.04 cm and estimated AFM% with no significant bias (−0.13%) and ±7.6% limits of agreement.

Conclusions

Both the model and ViScan are equally valid against DXA in estimating AFM%. However, ViScan is not valid in estimating WC in white postmenopausal women.

© 2013 by The North American Menopause Society

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.